AEM vs NWPX

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

NWPX exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and a very conservative debt-to-equity ratio of 0.28. However, the stock is severely overvalued, trading at $83.84—well above its Graham Number ($57.43) and Intrinsic Value ($24.92). This valuation gap is compounded by negative earnings growth (-9.7% YoY) and a bearish insider sentiment characterized by consistent selling from the CEO and Directors. Despite a rock-solid balance sheet, the divergence between the parabolic price action (+102% 1Y) and deteriorating fundamental growth suggests a high risk of correction.